Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.50    0.00 (0.00%)
Bid:
6.00
Ask:
7.00
Spread: 1.00 (16.667%)
Market Cap: £15.36m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Share Options

1 Apr 2010 12:26

RNS Number : 6351J
Symphony Environmental Tech. PLC
01 April 2010
 



 

 

1st April 2010

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

 

Share Options

 

 

Symphony Environmental Technologies Plc ("Symphony", the "Company" or the "Group") announces that the Board, on the recommendation of the Remuneration Committee, granted on 31st March 2010 share options to the Executive Directors of the Company in recognition of the results they have achieved in 2009.

 

A total of 1,050,000 options over the Company's ordinary 1p shares have been granted and allocated as to Michael Laurier 350,000; Ian Bristow 280,000; Michael Stephen 210,000; and Michael Stephens 210,000.

 

The options are exercisable for ten years at 9.125p per ordinary share being the mid market price on 31 March 2010.

 

Contacts:

 

Symphony Environmental Technologies plc

Michael Laurier, CEO

Ian Bristow, FD

  Tel: 020 8207 5900

 

Allenby Capital Limited

Nick Naylor/James Reeve

 

Tel: 020 3328 5656

Threadneedle Communications

Graham Herring/Josh Royston

 

Tel: 020 7653 9850

 

Symbol London. SYM.L

 

American Depositary Receipts ("ADR")

Symphony ADRs trade in the US on the OTC (Over The Counter) market under the symbol SETPY. The ADR to 1p ordinary share ratio is 1:100 and the CUSIP is 87156K104. BNY Mellon acts as sponsored depositary for Symphony's ADR facility.

 

 

Further information on the Symphony Environmental Technologies Group of companies:

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC considers itself a world leader in Controlled-life plastic technology and products - a system that works by a process called oxo-biodegradation. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products.

 

Symphony has a diverse and growing customer-base and has established itself successfully as an international business. Products made with d2w plastic technology can now be found in more than 90 countries around the world and in many different product applications. Symphony is a member of the Oxo-biodegradable Plastics Association (www.biodeg.org), the Society for the Chemical Industry (UK), and the American Standards Organisation (ASTM). Symphony is also a member of The US Save the Plastic Bag Coalition (http://www.savetheplasticbag.com/) and the British Brands Group. Symphony actively participates in the work of the British Standards Institute (BSI) and the European Standards Organisation (CEN).

 

Symphony also owns d2p which is an anti-microbial technology that is used in most type of plastic product applications to help protect those products against bacteria and fungi growth. Symphony is also developing innovative and cost-effective waste-to-value technology to convert plastics, tyres and other waste-streams into valuable products.

 

Further information on the Symphony Group can be found at www.d2w.net.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSIFFFFSSEEL
Date   Source Headline
29th May 201812:51 pmRNSDirector/PDMR Shareholding
21st May 20181:01 pmRNSExercise of Warrants and Director Dealing
15th May 20184:40 pmRNSSecond Price Monitoring Extn
15th May 20184:35 pmRNSPrice Monitoring Extension
15th May 201812:02 pmRNSResult of AGM
15th May 20187:01 amRNSAGM Statement
15th May 20187:00 amRNSTrading and Operations Update
3rd May 20187:00 amRNSNew Product Launches
1st May 20187:00 amRNSCollaboration Agreement and Strategic Investment
20th Apr 20187:00 amRNSSymphony Director on Sky News
19th Apr 20187:00 amRNSPosting of Accounts and Notice of AGM
18th Apr 20187:00 amRNSResults of YouGov survey
10th Apr 20187:00 amRNSOxo-biodegradable plastic legislation
9th Apr 20188:10 amRNSRemarks Delivered at 2018 ECOSOC Partnership Forum
6th Apr 20187:00 amRNSDirectorate Change
22nd Mar 201810:35 amRNSDirector Shareholding
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20183:57 pmRNSExercise of Options & Issue of New Ordinary Shares
2nd Mar 20187:00 amRNSExercise of Options
30th Jan 20187:00 amRNSIntroduction to d2w on the BBC World Service
12th Jan 201810:14 amRNSInterview on Sky News
8th Jan 20182:43 pmRNSDirector/PDMR Shareholding
4th Jan 20184:15 pmRNSExercise of Options
4th Jan 20184:09 pmRNSExercise of Options & Issue of New Ordinary
4th Jan 20187:00 amRNSTrading Update
15th Dec 20177:00 amRNSCourt Approval of Capital Reduction
30th Nov 20177:00 amRNSCapital Reduction Effective Date
8th Nov 201712:26 pmRNSResult of EGM
7th Nov 20171:57 pmRNSNotification of Major Holdings
27th Oct 20177:00 amRNSTrading Update
19th Oct 20177:00 amRNSProposed Capital Reduction & Notice of EGM
29th Sep 20177:00 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSInterim Results
11th Jul 20173:49 pmRNSHolding(s) in Company
31st May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20172:34 pmRNSDirector/PDMR Shareholding
12th May 201710:54 amRNSResult of AGM
12th May 20177:00 amRNSAGM Statement
9th May 20174:34 pmRNSExercise of Options
9th May 201710:47 amRNSExercise of Options
4th May 201711:25 amRNSDirector/PDMR Shareholding
3rd May 201711:29 amRNSExercise of Options and Director Dealing
25th Apr 20173:19 pmRNSDirector/PDMR Shareholding
25th Apr 20178:54 amRNSDirector/PDMR Shareholding
20th Apr 201712:43 pmRNSDirector/PDMR Shareholding
19th Apr 201712:31 pmRNSExercise of Options
19th Apr 20177:00 amRNSSaudi Arabia Legislation Enforcement
6th Apr 20177:00 amRNSAdmission of Securities to Trading on AIM
28th Mar 20178:27 amRNSExercise of Options and Issue of Equity
27th Mar 20178:13 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.